Low Dose Naltrexone Therapy

Low Dose Naltrexone (LDN) is used in the treatment of cancer as a long-term stabilization and/or gradual reduction of tumor mass volume.

How It Works

  • Induces increase of metenkephalin (an endorphin produced in large amounts in the adrenal medulla) and beta endorphin in the blood stream.
  • Induces increase in the number and density of opiate receptors on the tumor cell membranes by making them more responsive to the growth-inhibiting effects of the already-present levels of endorphins, which induce apoptosis (cell death) in cancer cells.
  • Increases the natural killer (NK) cell numbers and NK cell activity.

Cancers That Respond To LDN

  • Bladder Cancer
  • Breast Cancer
  • Carcinoid
  • Colon & Rectal Cancer
  • Glioblastoma
  • Liver Cancer
  • Lung Cancer (Non-Small Cell)
  • Lymphocytic Leukemia (Chronic)
  • Lymphoma (Hodgkin’s and Non-Hodgkin’s)
  • Malignant Melanoma
  • Multiple Myeloma
  • Beuroblastoma
  • Ovarian Cancer
  • Pancreatic Cancer
  • Prostate Cancer (Untreated)
  • Renal Cell Carcinoma
  • Throat Cancer
  • Uterine Cancer